~~<i id='C09C5F517E'><strike id='C09C5F517E'><tt id='C09C5F517E'><pre id='C09C5F517E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

explore

author：entertainment 2025-10-01 11:45:22 - browse：34

Pharmacists increasingly are being asked to make drugs in bulk for hospitals that are in short supply, and they’re even beginning to make chemotherapies. But some in the industry worry about the unintended consequences of overreliance.

Hospitals’ reliance on pharmacist-made drugs, a practice called compounding, has risen in step with worsening drug shortages.

When the American Society of Health-System Pharmacists surveyed its members this past summer, 59% said they increased purchases from compounders because of drug shortages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Data show record exodus of life scientists from academia

focus

hotspot

knowledge

focus

knowledge

focus

TheSenatehassetitseyesonregulatinginsuranceplansforsomeofthemostvulnerablepatientsintheU.S.— the12.5

WSS

Senator probes 340B programs at Cleveland Clinic, Bon Secours

Mindstrong's demise and the future of mental health care

Cigna to pay $172 million to settle Medicare Advantage fraud probe

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Republican states more likely to report Covid vaccine side effects

Cigna to pay $172 million to settle Medicare Advantage fraud probe

hotspot

explore

focus

ChatGPT in medicine: STAT answers readers' burning questions

Four alarming medical procedures we’re glad history forgot

The high cost of giving birth even with insurance

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Four alarming medical procedures we’re glad history forgot

Medicare proposal to cover medical devices draws a mixed reaction

Medicare Advantage 2025 payments will dip, Biden administration says

Anesthesiologist group: stop taking Ozempic before surgery

Intercept Pharmaceuticals sells itself for less than $1 billion

hotspot

Medicare Advantage 2025 payments will dip, Biden administration says

FDA advisers vote against ALS treatment from BrainStorm

Senator probes 340B programs at Cleveland Clinic, Bon Secours

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Paxlovid should be available without a positive Covid test

Inequities make cancer less preventable for women: report

knowledge

focus

knowledge

focus